par Allanore, Yannick;Khanna, Dinesh;Smith, Vanessa;Bondue, Benjamin 
;Hoffmann-Vold, Anna-Maria;Kuwana, Masataka;Merkel, Peter PA;Stock, Christian;Sambevski, Steven;Denton, Christopher Paul C.;SENSCIS Trial Investigators, Benjamin Bondue
Référence Rheumatology, 63, 3, page (639-647)
Publication Publié, 2024-03-01
;Hoffmann-Vold, Anna-Maria;Kuwana, Masataka;Merkel, Peter PA;Stock, Christian;Sambevski, Steven;Denton, Christopher Paul C.;SENSCIS Trial Investigators, Benjamin BondueRéférence Rheumatology, 63, 3, page (639-647)
Publication Publié, 2024-03-01
Article révisé par les pairs
| Résumé : | To investigate the course of interstitial lung disease (ILD) and the effects of nintedanib in patients with limited cutaneous systemic sclerosis (lcSSc). |
